BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 9473065)

  • 1. Clinical manifestations of mutations in the neurofibromatosis type 2 gene in vestibular schwannomas (acoustic neuromas).
    Welling DB
    Laryngoscope; 1998 Feb; 108(2):178-89. PubMed ID: 9473065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations of the neurofibromatosis type 2 gene and lack of the gene product in vestibular schwannomas.
    Sainz J; Huynh DP; Figueroa K; Ragge NK; Baser ME; Pulst SM
    Hum Mol Genet; 1994 Jun; 3(6):885-91. PubMed ID: 7951231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatic NF2 gene mutations in familial and non-familial vestibular schwannoma.
    Irving RM; Moffat DA; Hardy DG; Barton DE; Xuereb JH; Maher ER
    Hum Mol Genet; 1994 Feb; 3(2):347-50. PubMed ID: 8004107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas.
    Lekanne Deprez RH; Bianchi AB; Groen NA; Seizinger BR; Hagemeijer A; van Drunen E; Bootsma D; Koper JW; Avezaat CJ; Kley N
    Am J Hum Genet; 1994 Jun; 54(6):1022-9. PubMed ID: 7911002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The neurofibromatosis type 2 gene is inactivated in schwannomas.
    Twist EC; Ruttledge MH; Rousseau M; Sanson M; Papi L; Merel P; Delattre O; Thomas G; Rouleau GA
    Hum Mol Genet; 1994 Jan; 3(1):147-51. PubMed ID: 8162016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neurofibromatosis type 2 (NF2)].
    Araki N; Takeshima H; Saya H
    Gan To Kagaku Ryoho; 1997 Sep; 24(11):1427-31. PubMed ID: 9309136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A missense mutation in the NF2 gene results in moderate and mild clinical phenotypes of neurofibromatosis type 2.
    Kluwe L; Mautner VF
    Hum Genet; 1996 Feb; 97(2):224-7. PubMed ID: 8566958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular genetics alterations and tumor behavior of sporadic vestibular schwannoma from the People's Republic of China.
    Bian LG; Tirakotai W; Sun QF; Zhao WG; Shen JK; Luo QZ
    J Neurooncol; 2005 Jul; 73(3):253-60. PubMed ID: 15980976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up studies of Gamma Knife surgery for patients with neurofibromatosis Type 2.
    Sun S; Liu A
    J Neurosurg; 2014 Dec; 121 Suppl():143-9. PubMed ID: 25434947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined molecular genetic studies of chromosome 22q and the neurofibromatosis type 2 gene in central nervous system tumors.
    Ng HK; Lau KM; Tse JY; Lo KW; Wong JH; Poon WS; Huang DP
    Neurosurgery; 1995 Oct; 37(4):764-73. PubMed ID: 8559307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A group of schwannomas with interstitial deletions on 22q located outside the NF2 locus shows no detectable mutations in the NF2 gene.
    Bruder CE; Ichimura K; Tingby O; Hirakawa K; Komatsuzaki A; Tamura A; Yuasa Y; Collins VP; Dumanski JP
    Hum Genet; 1999 May; 104(5):418-24. PubMed ID: 10394935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of mutations in the SCH gene in schwannomas.
    Bijlsma EK; Merel P; Bosch DA; Westerveld A; Delattre O; Thomas G; Hulsebos TJ
    Genes Chromosomes Cancer; 1994 Sep; 11(1):7-14. PubMed ID: 7529050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular biology of vestibular schwannomas.
    Chang LS; Welling DB
    Methods Mol Biol; 2009; 493():163-77. PubMed ID: 18839347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular genetic analysis of the NF2 gene in young patients with unilateral vestibular schwannomas.
    Mohyuddin A; Neary WJ; Wallace A; Wu CL; Purcell S; Reid H; Ramsden RT; Read A; Black G; Evans DG
    J Med Genet; 2002 May; 39(5):315-22. PubMed ID: 12011146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential diagnosis of type 2 neurofibromatosis: molecular discrimination of NF2 and sporadic vestibular schwannomas.
    Wu CL; Thakker N; Neary W; Black G; Lye R; Ramsden RT; Read AP; Evans DG
    J Med Genet; 1998 Dec; 35(12):973-7. PubMed ID: 9863591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A point mutation associated with a severe phenotype of neurofibromatosis 2.
    MacCollin M; Braverman N; Viskochil D; Ruttledge M; Davis K; Ojemann R; Gusella J; Parry DM
    Ann Neurol; 1996 Sep; 40(3):440-5. PubMed ID: 8797533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NF2 genetic alterations in sporadic vestibular schwannomas: clinical implications.
    Lassaletta L; Torres-Martín M; Peña-Granero C; Roda JM; Santa-Cruz-Ruiz S; Castresana JS; Gavilan J; Rey JA
    Otol Neurotol; 2013 Sep; 34(7):1355-61. PubMed ID: 23921927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatic neurofibromatosis type 2 gene mutations and growth characteristics in vestibular schwannoma.
    Irving RM; Harada T; Moffat DA; Hardy DG; Whittaker JL; Xuereb JH; Maher ER
    Am J Otol; 1997 Nov; 18(6):754-60. PubMed ID: 9391673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. cDNA microarray analysis of vestibular schwannomas.
    Welling DB; Lasak JM; Akhmametyeva E; Ghaheri B; Chang LS
    Otol Neurotol; 2002 Sep; 23(5):736-48. PubMed ID: 12218628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational spectrum in the neurofibromatosis type 2 gene in sporadic and familial schwannomas.
    Welling DB; Guida M; Goll F; Pearl DK; Glasscock ME; Pappas DG; Linthicum FH; Rogers D; Prior TW
    Hum Genet; 1996 Aug; 98(2):189-93. PubMed ID: 8698340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.